These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4032755)

  • 1. [590-S].
    Furue H
    Gan No Rinsho; 1985 May; 31(6 Suppl):739-45. PubMed ID: 4032755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experiences with UFD-1].
    Furue H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):672-4. PubMed ID: 6820905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
    Nakatsu T; Takahashi H; Furue H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of 1-phthalidyl-5-fluorouracil (PH-FU)].
    Fujita H; Takao A; Okamoto M; Kimura K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2199-207. PubMed ID: 3717964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice].
    Shirasaka T; Fujita F; Fujita M; Fukushima M; Taguchi T; Fujii S
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1871-6. PubMed ID: 2393305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
    Fujita F; Fujita M; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):223-8. PubMed ID: 8434959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complex compounds of platinum in the chemotherapy of malignant tumors].
    Presnov MA; Konovalova AL; Korol'chuk VP
    Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phase I clinical study of a new fluorinated pyrimidine antineoplastic agent, TAC-278].
    Koyama Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):443-56. PubMed ID: 7184408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase I clinical study of TT-62. Research group of TT-62].
    Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):241-6. PubMed ID: 8434962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
    Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K
    Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
    Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
    Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].
    Shirasaka T; Fukushima M; Shimamoto Y; Kimura Y; Ohshimo H; Imaoka T; Kimura A; Utsunomiya T; Fujii S
    Gan To Kagaku Ryoho; 1990 May; 17(5):1051-8. PubMed ID: 2334171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the sensitivity test of carcinostatic agents by acid phosphatase activity.
    Imaizumi M
    Nagoya J Med Sci; 1972 Mar; 34(4):315-33. PubMed ID: 4665966
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FO-152].
    Furue H; Niitani H; Kurihara M; Hasegawa K; Nakao I; Tsukagoshi S; Fujita H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2251-6. PubMed ID: 3111381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I trial of N-methylformamide.
    McVie JG; ten Bokkel Huinink WW; Simonetti G; Dubbelman R
    Cancer Treat Rep; 1984 Apr; 68(4):607-10. PubMed ID: 6325001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor activity of prospidin].
    Sorkina IuA; Chernov VA; Grushina AA; Khramchenkova SP
    Vopr Onkol; 1970; 16(7):83-6. PubMed ID: 5274101
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.